During the first semester of 2019, companies from Central American countries bought $20 million in vaccines for animal use abroad, and 55% was imported by companies in Guatemala and Costa Rica.
Figures from the Trade Intelligence Unit at CentralAmericaData: [GRAFICA caption="Click to interact with graphics"]
From January to October 2019, purchases of pharmaceutical products made by Central American countries from companies in Mexico totaled $232 million, and 63% was purchased by companies in Panama and Costa Rica.
Figures from the Trade Intelligence Unit at CentralAmericaData: [GRAFICA caption="Click to interact with graphics"]
In the first half of 2019, purchases of vaccines for human use in Central America totaled $122 million, 116% more than was reported in the same period in 2018.
Figures from the Trade Intelligence Unit at CentralAmericaData: [GRAPHIC caption="Click to interact with graphic"]
In the first six months of the year, imports of pharmaceutical products in Central America totaled $1.717 million, 8% more than in the same period in 2018.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graphic"]
In the first quarter of 2019, purchases of vaccines for human use in Central America totaled $66 million, 347% more than was reported in the same period in 2018.
Figures from the Trade Intelligence Unit at CentralAmericaData: [GRAPHIC caption="Click to interact with graphic"]
Because the country produces only 6% of the medicines demanded, there are several business opportunities that can be explored by industry businessmen.
Currently, local manufacturers do not have the capacity to produce and supply the Panamanian market, which has generated several business opportunities for several companies.
In El Salvador, 51 private pharmacies in 28 municipalities are tendered for supply and delivery to serve the ISBM user population for the rest of the year.
El Salvador Government Purchase LP-014/2019-ISBM:
"By the nature of the purchase of the Instituto Salvadoreno de Bienestar Magisterial the award may be partial, according to the number of pharmacies required in each of the places specified in the specifications.
In the first three months of the year, imports of pharmaceutical products in Central America totaled $835 million, 15% more than in the same period in 2018.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAPHIC caption="Click to interact with graphic"]
In the first half of 2019, purchases of pharmaceutical products made by Central American countries to companies in Mexico totaled $140 million, 7% less than in the same period of 2018.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]
Agencia Farmacéutica Internacional, Meditek Services and Baxter are three of the companies that in the first quarter of 2019 were awarded contracts to provide medicines to public health institutions in the region.
An analysis of CentralAmericaData's Trade Intelligence unit provides data on the companies that were favored last year with contracts to supply pharmaceutical products and medical supplies to the different Ministries of Health and Social Security entities in Central American countries.
During the first nine months of 2018, Central American countries purchased $32 million in vaccines for animal use abroad, 17% more than in the same period in 2017.
Figures from the Trade Intelligence Unit at CentralAmericaData: [GRAFICA caption="Click to interact with graphics]
American Drugstore and C. Imberton were sanctioned for proving "that they engaged in the anti-competitive practice of agreeing to fix the prices of Cataflam, Diovan and Lamisil products."
The Superintendence of Competition of El Salvador (SC) sanctioned American Drugstore, for $171,000, and C. Imberton, for $228,000, after proving that they engaged in the anticompetitive practice of agreeing to fix the prices of the products concerned, informed the institution.